Psycheceutical Bioscience Inc BWVI
$0.00
Last Updated: Aug 11, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Psycheceutical Bioscience Inc. Stock Analysis BWVI
United States N/A Nano Cap Psycheceutical Bioscience, Inc. engages in psychedelic medicine and represents the potential for major progress in the area of mental health treatment. The company is headquartered in Fleming Island, Florida and currently employs 28 full-time employees. The company went IPO on 2007-05-25. The Company’s patented NeuroDirect non-systemic delivery technology is designed to deliver neuro-active compounds directly into the nerve tissue via topical application at the back of the neck. The delivery system is intended to enable immediate and sustained delivery, safe dosage control, and consistent results-while avoiding the GI tract and any unwanted side effects and toxicity. The company has designed a product that improves the quality of life for those suffering from Post-Traumatic Stress Disorder (PTSD) and Chronic Regional Pain Syndrome (CRPS). Its pipeline program includes the PSY-007-KETAMINE. The company focuses on commercializing its precision dosing technologies to provide affordable, life-saving treatments to anyone suffering from mental health disorders or central nervous system diseases.
Psycheceutical Bioscience Inc (BWVI) Chart
Financial Metrics & Statements of Psycheceutical Bioscience Inc (BWVI)
FAQ's for Psycheceutical Bioscience Inc (BWVI)
- As of August 2026, Psycheceutical Bioscience Inc BWVI is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Psycheceutical Bioscience Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Psycheceutical Bioscience Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Psycheceutical Bioscience Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Psycheceutical Bioscience Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Psycheceutical Bioscience Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Psycheceutical Bioscience Inc (BWVI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
